Evidence map›Paper›PMID 29063425›Full record

ArticleJournal of neuro-oncology2018

Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.

Sophie E M Veldhuijzen van Zanten, Fatma E El-Khouly, Marc H A Jansen, Dewi P Bakker, Esther Sanchez Aliaga, Cornelis J A Haasbeek, Nicole I Wolf, C Michel Zwaan, W Peter Vandertop, Dannis G van Vuurden and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sophie E M Veldhuijzen van ZantenDepartment of Pediatric Oncology ‑ Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Fatma E El-KhoulyDepartment of Pediatric Oncology ‑ Hematology, VU University Medical Center, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1451-8516
Marc H A JansenDepartment of Pediatric Oncology ‑ Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Dewi P BakkerDepartment of Child Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Esther Sanchez AliagaDepartment of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
Cornelis J A HaasbeekDepartment of Radiotherapy, VU University Medical Center, Amsterdam, The Netherlands.
Nicole I WolfDepartment of Child Neurology, VU University Medical Center, Amsterdam, The Netherlands.
C Michel ZwaanDepartment of Pediatric Oncology ‑ Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
W Peter VandertopNeurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Dannis G van VuurdenDepartment of Pediatric Oncology ‑ Hematology, VU University Medical Center, Amsterdam, The Netherlands. dg.vanvuurden@vumc.nl.
Gertjan J L KaspersDepartment of Pediatric Oncology ‑ Hematology, VU University Medical Center, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Table 2 of the original publication, there were errors in the baseline scores for the PedsQL TM 3.0 Cancer Module questionnaire, so a corrected version of Table 2 is shown in this erratum. In the subcategories of the PedsQL TM 3.0 Cancer Module questionnaire, nausea and fear of procedure did not score significantly lower after treatment compared to baseline. So, based on the corrected data in Table 2, there was no significant decrease in the total score of the cancer questionnaire, and this statement in the previous manuscript was incorrect.

Identifiers

PMID29063425
PMCPMC6828194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.